The ICON angle as the eventual JV or Lympro buyout
Post# of 30028
Posted On: 09/18/2014 5:26:24 PM
Re: gobears1985 #6788
The ICON angle as the eventual JV or Lympro buyout candidate does make a lot of sense. They have the most to lose financially if AMBS decides to sell or deal with another pharma. I wonder if ICON has the right of first refusal should someone come a calllin and want to partner or buy Lympro. I would guess that ICON wants to see how Lympro does first before making an offer. But that's my baseless speculation.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
Scroll down for more posts ▼